Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Adverum Biotechnologies, Inc. ADVM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+244%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Adverum Biotechnologies, Inc. (ADVM), dont 39 achats et 11 ventes. Le total des achats d'initiés s'élève à $9.09M et le total des ventes d'initiés à $13.71M.

Les initiés notables ayant une activité récente comprennent Whitcup Scott M, Machado Patrick, Rubinstein Linda M. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ADVM

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2025-06-17 Whitcup Scott M Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Machado Patrick Director Attribution de RSU 3,140 $2.32 $7.28K 3,140
2025-06-17 Rubinstein Linda M Chief Financial Officer Restitution d'Actions 35,000 $19.90 $696.5K -
2025-06-17 Scopa James Paul Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Fischer Laurent CEO, President and Director Restitution d'Actions 68,000 $134.40 $9.14M -
2025-06-17 Tuckson Reed Vaughn Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Svoronos Dawn Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Nicholson, C. David Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Soparkar Peter Chief Operating Officer Restitution d'Actions 40,000 $68.80 $2.75M -
2025-06-17 Lupher, Jr. Mark L. Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Ozden Rabia Gurses Chief Medical Officer Restitution d'Actions 8,000 $13.50 $108K -
2025-06-17 Seyedkazemi Setareh Chief Development Officer Restitution d'Actions 8,500 $12.90 $109.65K -
2025-06-17 Hong Soo Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-17 Kiss Szilard Director Attribution de RSU 10,450 $2.32 $24.24K 10,450
2025-06-10 Seyedkazemi Setareh Chief Development Officer Restitution d'Actions 40,000 $19.90 $796K -
2025-05-15 Fischer Laurent CEO, President and Director Vente Informative 9,126 $2.00 $18.25K 87,488
2025-05-15 Soparkar Peter Chief Operating Officer Vente Informative 2,960 $2.00 $5.92K 39,154
2025-05-15 Seyedkazemi Setareh Chief Development Officer Vente Informative 924 $2.00 $1.85K 13,768
2025-04-23 Leonard Braden Michael 10 Percent Owner Achat Informatif 50,000 $2.98 $148.95K 191,800
2025-04-22 Leonard Braden Michael 10 Percent Owner Achat Informatif 300,000 $3.00 $900K 3,057,526
2025-04-02 Leonard Braden Michael 10 Percent Owner Achat Informatif 15,209 $4.04 $61.41K 2,757,526
2025-03-31 Leonard Braden Michael 10 Percent Owner Achat Informatif 19,566 $4.38 $85.67K 2,742,317
2025-03-27 Leonard Braden Michael 10 Percent Owner Vente Informative 16,593 $5.19 $86.09K 141,800
2025-03-27 Leonard Braden Michael 10 Percent Owner Achat Informatif 16,593 $5.19 $86.09K 141,800
2025-03-26 Leonard Braden Michael 10 Percent Owner Achat Informatif 20,407 $5.04 $102.84K 125,207
2025-03-20 Leonard Braden Michael 10 Percent Owner Achat Informatif 30,600 $5.61 $171.77K 2,722,761
2025-03-19 Leonard Braden Michael 10 Percent Owner Achat Informatif 25,000 $4.94 $123.39K 2,692,161
2025-03-18 Leonard Braden Michael 10 Percent Owner Achat Informatif 18,000 $4.60 $82.8K 2,622,820
2025-02-28 Leonard Braden Michael 10 Percent Owner Achat Informatif 85,068 $4.60 $391.02K 2,604,820
2025-02-27 Leonard Braden Michael 10 Percent Owner Achat Informatif 86,802 $4.46 $387.09K 2,519,752
2025-02-26 Leonard Braden Michael 10 Percent Owner Achat Informatif 164,886 $4.01 $660.98K 2,432,950
2025-02-25 Rubinstein Linda M Chief Financial Officer Attribution de RSU 8,125 - - 19,325
2025-02-25 Fischer Laurent CEO, President and Director Attribution de RSU 25,000 - - 96,614
2025-02-25 Soparkar Peter Chief Operating Officer Attribution de RSU 13,125 - - 42,114
2025-02-25 Ozden Rabia Gurses Chief Medical Officer Attribution de RSU 8,125 - - 8,125
2025-02-25 Seyedkazemi Setareh Chief Development Officer Attribution de RSU 8,125 - - 14,692
2024-08-02 Rubinstein Linda M Chief Financial Officer Attribution de RSU 62,083 $7.15 $443.89K 62,083
2024-08-02 Fischer Laurent CEO, President and Director Attribution de RSU 200,000 $7.15 $1.43M 200,000
2024-08-02 Soparkar Peter Chief Operating Officer Attribution de RSU 64,394 $7.15 $460.42K 64,394
2024-08-02 Ozden Rabia Gurses Chief Medical Officer Attribution de RSU 44,010 $7.15 $314.67K 44,010
2024-08-02 Seyedkazemi Setareh Chief Development Officer Attribution de RSU 43,458 $7.15 $310.72K 43,458
2024-07-30 Leonard Braden Michael 10 Percent Owner Achat Informatif 85,800 $7.15 $613.47K 2,268,064
2024-07-18 Leonard Braden Michael 10 Percent Owner Achat Informatif 80,718 $9.11 $735.74K 2,182,264
2024-07-17 Leonard Braden Michael 10 Percent Owner Cession - - - 104,800
2024-07-17 Leonard Braden Michael 10 Percent Owner Achat Informatif 135,546 $7.75 $1.05M 2,101,546
2024-06-17 Whitcup Scott M Director Attribution de RSU 10,520 $7.32 $77.01K 10,520
2024-06-17 Machado Patrick Director Attribution de RSU 3,300 $7.32 $24.16K 3,300
2024-06-17 Scopa James Paul Director Attribution de RSU 10,520 $7.32 $77.01K 10,520
2024-06-17 Tuckson Reed Vaughn Director Attribution de RSU 10,520 $7.32 $77.01K 10,520
2024-06-17 Svoronos Dawn Director Attribution de RSU 10,520 $7.32 $77.01K 10,520
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message